Use access key #2 to skip to page content.
$5.43 0.27 (5.23%)
10/13/2008 4:00 PM

Dendreon Corp (DNDN)

CAPS Rating:
**

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

View All Commentary (DNDN)

Recs

0

Avatar socialistnyc (79.34) Submitted: 5/06/08 12:25 PM : Outperform Start Price: $5.08 DNDN Score: 43.28

How could you not root for a company that has developed a drug to fight prostate and breast cancer? They have been approved to sell their drugs in Europe and when the FDA approves them, they will skyrocket!

Report this Post Replies: 0 | Reply

Featured Broker Partners